Ergomed PLC | Mutual Funds
Mutual Funds that own Ergomed PLC
MFM Slater Growth Fund
2,900,000
6.47%
0
1.08%
04/28/2017
S&W Wood Street Micro Cap Investment Fund
1,105,000
2.46%
105,000
1.92%
09/29/2017
Octopus AIM VCT 2 Plc
580,930
1.3%
-4,985
1.31%
05/31/2017
Cavendish Investments Funds - AIM Fund
523,500
1.17%
0
1.14%
07/31/2018
Cavendish Investments Funds - Opportunities Fund
460,900
1.03%
0
0.57%
07/31/2018
334,738
0.75%
334,738
0.07%
06/30/2018
Apus Capital Revalue Fonds
325,000
0.72%
0
0.4%
09/30/2017
202,407
0.45%
-29,537
0.79%
06/29/2018
90,000
0.2%
90,000
1.18%
11/30/2016
33,726
0.08%
-1,000
0.43%
06/29/2018
| Address |
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
|
|
Employees
|
- |
| Website |
http://ergomedplc.com/ |
| Updated |
07/08/2019 |
| Ergomed Plc is a clinical development company. The company is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. It focuses on the development of oncology, neurology and immunology drugs. |
